Russia has restructured state pharmaceutical procurement to progressively exclude foreign manufacturers who do not act. The mechanism being used is the “second-out” rule: Where a qualifying local competitor submits a bid in a Russian state tender, the foreign manufacturer’s bid is rejected—regardless of price or quality. This principle has applied to the Essential Drug List since January 2025 and is expected to extend at least to the Strategic Drugs List in July 2026.

Australia: In this session, we provide an overview of the key legal cases and laws impacting on pay compliance in 2026. Join Partner Helene Lee and Senior Associate Angela Cartwright as they outline what employers cannot afford to get wrong.

Australia: Australia’s payroll compliance landscape continues to change. As the regulatory spotlight intensifies, proactive compliance is essential. For an overview of key payroll risks, recent enforcement trends, and the practical steps employers should take, read the full article.